CONSTELLIUM SE Financial Summary

Quick Answer

CONSTELLIUM SE reported Total Revenue of $8.45 billion for fiscal year 2025.

CONSTELLIUM SE — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $8.45B
+15.2%
$7.33B
-6.3%
$7.83B
-8.3%
$8.53B
Revenue (ASC 606) $8.45B
+15.2%
$7.33B
-6.3%
$7.83B
-8.3%
$8.53B
Net Income $273.00M
+387.5%
$56.00M
-63.2%
$152.00M
-50.6%
$308.00M
Diluted EPS $1.92
+405.3%
$0.38
-63.1%
$1.03
-51.0%
$2.10
Total Assets $5.35B
+13.1%
$4.73B
-4.0%
$4.93B
-0.2%
$4.94B
+6.9%
$4.62B
+12.0%
$4.13B
-1.3%
Cash and Equivalents $120.00M
-14.9%
$141.00M
-36.8%
$223.00M
Stockholders Equity $952.00M
+34.8%
$706.00M
-1.7%
$718.00M
+19.1%
$603.00M
+424.3%
$115.00M
R&D Expense $51.00M
+4.1%
$49.00M
-5.8%
$52.00M
+13.0%
$46.00M
+17.9%
$39.00M
+0.0%
$39.00M
-18.8%
Gross Profit $710.00M
+5.7%
$672.00M
+1.2%
$664.00M
+35.5%
$490.00M
-18.6%
Shares Outstanding 135.42M
-5.6%
143.52M

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2025 $2.17B +20.2% +3.0%
Revenue (ASC 606) September 30, 2025 $2.17B +20.2% +3.0%
Net Income September 30, 2025 $88.00M +1157.1% +144.4%
Diluted EPS September 30, 2025 $0.62 +1140.0% +148.0%
Total Assets September 30, 2025 $5.38B +0.1%
Cash and Equivalents September 30, 2025 $122.00M -8.3%
Stockholders Equity September 30, 2025 $845.00M +5.1% +8.3%
R&D Expense September 30, 2025 $12.00M +9.1% +0.0%
  • CONSTELLIUM SE reported Total Revenue of $8.45 billion for fiscal year 2025.
  • CONSTELLIUM SE showed an increase of +15.2% in Total Revenue compared to the prior fiscal year.
  • CONSTELLIUM SE reported Revenue (ASC 606) of $8.45 billion for fiscal year 2025.
  • CONSTELLIUM SE showed an increase of +15.2% in Revenue (ASC 606) compared to the prior fiscal year.
  • CONSTELLIUM SE reported Net Income of $273.00 million for fiscal year 2025.
  • CONSTELLIUM SE showed an increase of +387.5% in Net Income compared to the prior fiscal year.
  • CONSTELLIUM SE reported Diluted EPS of $1.92 per share for fiscal year 2025.
  • CONSTELLIUM SE showed an increase of +405.3% in Diluted EPS compared to the prior fiscal year.
  • CONSTELLIUM SE reported Total Assets of $5.35 billion for fiscal year 2025.
  • CONSTELLIUM SE showed an increase of +13.1% in Total Assets compared to the prior fiscal year.
  • CONSTELLIUM SE reported Cash and Equivalents of $120.00 million for fiscal year 2025.
  • CONSTELLIUM SE showed a decrease of -14.9% in Cash and Equivalents compared to the prior fiscal year.
  • CONSTELLIUM SE reported Stockholders Equity of $952.00 million for fiscal year 2025.
  • CONSTELLIUM SE showed an increase of +34.8% in Stockholders Equity compared to the prior fiscal year.
  • CONSTELLIUM SE reported R&D Expense of $51.00 million for fiscal year 2025.
  • CONSTELLIUM SE showed an increase of +4.1% in R&D Expense compared to the prior fiscal year.
  • CONSTELLIUM SE reported Gross Profit of $710.00 million for fiscal year 2023.
  • CONSTELLIUM SE showed an increase of +5.7% in Gross Profit compared to the prior fiscal year.
  • CONSTELLIUM SE reported Shares Outstanding of 135.42 million shares for fiscal year 2025.
  • CONSTELLIUM SE showed a decrease of -5.6% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment